00002-5562 RETEVMO - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00002-5562

Brand Name:

RETEVMO

Generic Name:

Selpercatinib

Dosage Form Name:

TABLET, COATED

Administration Route:

Oral

Substances:

Name: SELPERCATINIB

Strength: 160.0

Unit: mg/1

Packages:

Code: 00002-5562-60

Description: 60 TABLET, COATED in 1 BOTTLE (0002-5562-60)

Effective Date: April 10, 2024

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

VEGFR, RET

Orphan Drug Designation:

Status:

In Use